Poly(ethylene glycol)-Mediated Assembly of Vaccine Particles to Improve Stability and Immunogenicity

  • Guiqiang Zhang
  • , Xiao Fu
  • , Haifeng Sun
  • , Peiyu Zhang
  • , Shumei Zhai
  • , Jingcheng Hao
  • , Jiwei Cui*
  • , Ming Hu*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Abstract

We report the one-step assembly of vaccine particles by encapsulating ovalbumin (OVA) and cytosine-phosphate-guanine oligodeoxynucleotides (CpG) into poly(ethylene glycol) (PEG)-mediated zeolitic imidazolate framework-8 nanoparticles (OVA-CpG@ZIF-8 NPs), where PEG improves the stability and dispersity of ZIF-8 NPs and the NPs protect the encapsulated OVA and CpG to circumvent the cold chain issue. Compared with free OVA and OVA-encapsulated ZIF-8 (OVA@ZIF-8) NPs, OVA-CpG@ZIF-8 NPs can enhance antigen uptake, cross-presentation, dendritic cell (DC) maturation, production of specific antibody and cytokines, and CD4+ T and CD8+ T cell activation. More importantly, the vaccine particles retain their bioactivity against enzymatic degradation, elevated temperatures, and long-term storage at ambient temperature. The study highlights the importance of PEG-mediated ZIF-8 NPs as a vaccine delivery system for the promising application of effective and cold chain-independent vaccination against diseases.

Original languageEnglish
Pages (from-to)13978-13989
Number of pages12
JournalACS Applied Materials and Interfaces
Volume13
Issue number12
DOIs
StatePublished - 31 Mar 2021

Keywords

  • cold chain
  • immunogenicity
  • metal-organic frameworks
  • poly(ethylene glycol)
  • vaccine delivery

Fingerprint

Dive into the research topics of 'Poly(ethylene glycol)-Mediated Assembly of Vaccine Particles to Improve Stability and Immunogenicity'. Together they form a unique fingerprint.

Cite this